Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge
- PMID: 19646670
- DOI: 10.1016/j.jpag.2008.09.002
Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge
Abstract
Study objective: Human papillomavirus (HPV), the most common sexually transmitted infection in the United States, can be contracted by young girls shortly after sexual debut. Human papillomavirus can lead to cervical and anogenital cancers and genital warts. A vaccine has been developed to protect against precancerous lesions. We examined obstetrician-gynecologists' practices, opinions, and knowledge regarding this vaccine.
Design: A 37-item questionnaire was sent out by the American College of Obstetricians and Gynecologists (ACOG) to its fellows and junior fellows between May and November of 2007.
Participants: Surveys went to 3896 fellows and junior fellows of ACOG. Of these surveys, 771 were Collaborative Ambulatory Research Network (CARN) members who have volunteered to receive several surveys per year. The remaining 3125 questionnaires were sent to all fellows and junior fellows in ACOG's District V (Ohio, Kentucky, Indiana, Michigan and Ontario, Canada). Response rates were 51.0% and 30.7% for CARN and District V, respectively.
Results: Of those who administer vaccines, most offer the HPV vaccine. Most know this vaccine protects against 4 HPV types. Fewer knew the percentages of cervical cancers and genital warts prevented. Over 20% knew all 3 answers. Only a minority answered all incorrectly. Approximately 15% view HPV vaccine as safe in pregnancy. Many agree cost is a reason for patient refusal and a deterrent from mandating the vaccine.
Conclusion: Obstetrician-gynecologists are knowledgeable of the HPV vaccine and are incorporating it into practice. Financial concerns may limit widespread immunization.
Similar articles
-
Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization.Obstet Gynecol Surv. 2009 Dec;64(12):823-9. doi: 10.1097/OGX.0b013e3181c4bbb7. Obstet Gynecol Surv. 2009. PMID: 19939296
-
Obstetrician-gynecologists' practices and perceived knowledge regarding immunization.Am J Prev Med. 2009 Sep;37(3):231-4. doi: 10.1016/j.amepre.2009.05.019. Epub 2009 Jul 10. Am J Prev Med. 2009. PMID: 19596538
-
Human papillomavirus vaccine: a paradigm shift for pediatricians.Curr Opin Pediatr. 2009 Feb;21(1):112-21. doi: 10.1097/MOP.0b013e3283207f93. Curr Opin Pediatr. 2009. PMID: 19242247 Review.
-
Prophylactic HPV vaccines: new interventions for cancer control.Vaccine. 2008 Nov 18;26(49):6244-57. doi: 10.1016/j.vaccine.2008.07.056. Epub 2008 Aug 9. Vaccine. 2008. PMID: 18694795 Review.
-
Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.Infect Dis Obstet Gynecol. 2004 Sep-Dec;12(3-4):127-33. doi: 10.1080/10647440400020661. Infect Dis Obstet Gynecol. 2004. PMID: 15763912 Free PMC article.
Cited by
-
A global study on knowledge and perception of HPV and HPV vaccination among young obstetricians and gynecologists.Turk J Obstet Gynecol. 2024 Mar 4;21(1):51-56. doi: 10.4274/tjod.galenos.2024.31369. Turk J Obstet Gynecol. 2024. PMID: 38440968 Free PMC article.
-
Conceiving an application ontology to model patient human papillomavirus vaccine counseling for dialogue management.BMC Bioinformatics. 2019 Dec 23;20(Suppl 21):706. doi: 10.1186/s12859-019-3193-7. BMC Bioinformatics. 2019. PMID: 31865902 Free PMC article.
-
Health Care Providers' Knowledge of HPV Vaccination, Barriers, and Strategies in a State With Low HPV Vaccine Receipt: Mixed-Methods Study.JMIR Cancer. 2017 Aug 11;3(2):e12. doi: 10.2196/cancer.7345. JMIR Cancer. 2017. PMID: 28801303 Free PMC article.
-
Promoting and Providing HPV Vaccination in Hawaii: Barriers Faced by Health Providers.J Community Health. 2016 Oct;41(5):1069-77. doi: 10.1007/s10900-016-0191-9. J Community Health. 2016. PMID: 27038960 Free PMC article.
-
Identification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.Hum Vaccin Immunother. 2016 Jun 2;12(6):1639-45. doi: 10.1080/21645515.2015.1110658. Epub 2016 Feb 2. Hum Vaccin Immunother. 2016. PMID: 26839185 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical